{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,13]],"date-time":"2026-11-13T13:32:57Z","timestamp":1794576777922,"version":"4.9.1"},"reference-count":164,"publisher":"Springer Science and Business Media LLC","issue":"12","license":[{"start":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T00:00:00Z","timestamp":1760054400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T00:00:00Z","timestamp":1760054400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nat Rev Cancer"],"published-print":{"date-parts":[[2025,12]]},"DOI":"10.1038\/s41568-025-00864-1","type":"journal-article","created":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T09:11:04Z","timestamp":1760087464000},"page":"910-924","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":148,"title":["Decoding ferroptosis for cancer therapy"],"prefix":"10.1038","volume":"25","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-8856-8834","authenticated-orcid":false,"given":"Adam","family":"Wahida","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1140-5612","authenticated-orcid":false,"given":"Marcus","family":"Conrad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,10,10]]},"reference":[{"key":"864_CR1","doi-asserted-by":"publisher","first-page":"1407","DOI":"10.1038\/s41556-024-01425-8","volume":"26","author":"T Nakamura","year":"2024","unstructured":"Nakamura, T. & Conrad, M. Exploiting ferroptosis vulnerabilities in cancer. Nat. Cell Biol. 26, 1407\u20131419 (2024).","journal-title":"Nat. Cell Biol."},{"key":"864_CR2","doi-asserted-by":"publisher","first-page":"405","DOI":"10.1038\/s41568-019-0149-1","volume":"19","author":"JP Friedmann Angeli","year":"2019","unstructured":"Friedmann Angeli, J. P., Krysko, D. V. & Conrad, M. Ferroptosis at the crossroads of cancer-acquired drug resistance and immune evasion. Nat. Rev. Cancer 19, 405\u2013414 (2019).","journal-title":"Nat. Rev. Cancer"},{"key":"864_CR3","doi-asserted-by":"publisher","first-page":"1378","DOI":"10.1002\/1878-0261.13649","volume":"18","author":"FI Yapici","year":"2024","unstructured":"Yapici, F. I., Bebber, C. M. & von Karstedt, S. A guide to ferroptosis in cancer. Mol. Oncol. 18, 1378\u20131396 (2024).","journal-title":"Mol. Oncol."},{"key":"864_CR4","doi-asserted-by":"publisher","first-page":"2401","DOI":"10.1016\/j.cell.2022.06.003","volume":"185","author":"BR Stockwell","year":"2022","unstructured":"Stockwell, B. R. Ferroptosis turns 10: emerging mechanisms, physiological functions, and therapeutic applications. Cell 185, 2401\u20132421 (2022).","journal-title":"Cell"},{"key":"864_CR5","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1038\/s41589-024-01794-z","volume":"21","author":"M Conrad","year":"2025","unstructured":"Conrad, M. & Wahida, A. The many paths ascending to ferroptosis. Nat. Chem. Biol. 21, 18\u201319 (2025).","journal-title":"Nat. Chem. Biol."},{"key":"864_CR6","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1002\/biof.5520140123","volume":"14","author":"M Brielmeier","year":"2001","unstructured":"Brielmeier, M. et al. Cloning of phospholipid hydroperoxide glutathione peroxidase (PHGPx) as an anti-apoptotic and growth promoting gene of Burkitt lymphoma cells. Biofactors 14, 179\u2013190 (2001). This early work identifies both GPX4 and a putative peroxiredoxin-type NADH oxidase, which later turned out to be FSP1, as critical survival factors for Burkitt lymphoma cells.","journal-title":"Biofactors"},{"key":"864_CR7","doi-asserted-by":"publisher","first-page":"231","DOI":"10.1007\/s00726-011-0867-5","volume":"42","author":"M Conrad","year":"2012","unstructured":"Conrad, M. & Sato, H. The oxidative stress-inducible cystine\/glutamate antiporter, system xc\u2013: cystine supplier and beyond. Amino Acids 42, 231\u2013246 (2012).","journal-title":"Amino Acids"},{"key":"864_CR8","doi-asserted-by":"publisher","first-page":"11455","DOI":"10.1074\/jbc.274.17.11455","volume":"274","author":"H Sato","year":"1999","unstructured":"Sato, H., Tamba, M., Ishii, T. & Bannai, S. Cloning and expression of a plasma membrane cystine\/glutamate exchange transporter composed of two distinct proteins. J. Biol. Chem. 274, 11455\u201311458 (1999).","journal-title":"J. Biol. Chem."},{"key":"864_CR9","doi-asserted-by":"publisher","first-page":"665","DOI":"10.1089\/ars.2000.2.4-665","volume":"2","author":"H Sato","year":"2000","unstructured":"Sato, H., Tamba, M., Kuriyama-Matsumura, K., Okuno, S. & Bannai, S. Molecular cloning and expression of human xCT, the light chain of amino acid transport system xc\u2013. Antioxid. Redox Signal. 2, 665\u2013671 (2000).","journal-title":"Antioxid. Redox Signal."},{"key":"864_CR10","doi-asserted-by":"publisher","first-page":"285","DOI":"10.1016\/S1535-6108(03)00050-3","volume":"3","author":"S Dolma","year":"2003","unstructured":"Dolma, S., Lessnick, S. L., Hahn, W. C. & Stockwell, B. R. Identification of genotype-selective antitumor agents using synthetic lethal chemical screening in engineered human tumor cells. Cancer Cell 3, 285\u2013296 (2003). This seminal work by the Stockwell group identifies key compounds that would propel the field of interrogating ferroptosis using small molecules.","journal-title":"Cancer Cell"},{"key":"864_CR11","doi-asserted-by":"publisher","first-page":"234","DOI":"10.1016\/j.chembiol.2008.02.010","volume":"15","author":"WS Yang","year":"2008","unstructured":"Yang, W. S. & Stockwell, B. R. Synthetic lethal screening identifies compounds activating iron-dependent, nonapoptotic cell death in oncogenic-RAS-harboring cancer cells. Chem. Biol. 15, 234\u2013245 (2008).","journal-title":"Chem. Biol."},{"key":"864_CR12","doi-asserted-by":"publisher","first-page":"266","DOI":"10.1038\/s41580-020-00324-8","volume":"22","author":"X Jiang","year":"2021","unstructured":"Jiang, X., Stockwell, B. R. & Conrad, M. Ferroptosis: mechanisms, biology and role in disease. Nat. Rev. Mol. Cell Biol. 22, 266\u2013282 (2021).","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"864_CR13","doi-asserted-by":"publisher","first-page":"379","DOI":"10.1038\/s41580-023-00689-6","volume":"25","author":"J Yuan","year":"2024","unstructured":"Yuan, J. & Ofengeim, D. A guide to cell death pathways. Nat. Rev. Mol. Cell Biol. 25, 379\u2013395 (2024).","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"864_CR14","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1016\/j.cell.2023.11.044","volume":"187","author":"K Newton","year":"2024","unstructured":"Newton, K., Strasser, A., Kayagaki, N. & Dixit, V. M. Cell death. Cell 187, 235\u2013256 (2024).","journal-title":"Cell"},{"key":"864_CR15","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1021\/acscentsci.9b01063","volume":"6","author":"VAN Kraft","year":"2020","unstructured":"Kraft, V. A. N. et al. GTP cyclohydrolase 1\/tetrahydrobiopterin counteract ferroptosis through lipid remodeling. ACS Cent. Sci. 6, 41\u201353 (2020).","journal-title":"ACS Cent. Sci."},{"key":"864_CR16","doi-asserted-by":"publisher","first-page":"1351","DOI":"10.1038\/s41589-020-0613-y","volume":"16","author":"M Soula","year":"2020","unstructured":"Soula, M. et al. Metabolic determinants of cancer cell sensitivity to canonical ferroptosis inducers. Nat. Chem. Biol. 16, 1351\u20131360 (2020).","journal-title":"Nat. Chem. Biol."},{"key":"864_CR17","doi-asserted-by":"publisher","first-page":"941","DOI":"10.1016\/j.immuni.2024.03.019","volume":"57","author":"HN Bell","year":"2024","unstructured":"Bell, H. N., Stockwell, B. R. & Zou, W. Ironing out the role of ferroptosis in immunity. Immunity 57, 941\u2013956 (2024).","journal-title":"Immunity"},{"key":"864_CR18","doi-asserted-by":"publisher","first-page":"499","DOI":"10.1038\/s41580-022-00456-z","volume":"23","author":"H Sies","year":"2022","unstructured":"Sies, H. et al. Defining roles of specific reactive oxygen species (ROS) in cell biology and physiology. Nat. Rev. Mol. Cell Biol. 23, 499\u2013515 (2022).","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"864_CR19","doi-asserted-by":"publisher","first-page":"701","DOI":"10.1038\/s41580-024-00730-2","volume":"25","author":"H Sies","year":"2024","unstructured":"Sies, H., Mailloux, R. J. & Jakob, U. Fundamentals of redox regulation in biology. Nat. Rev. Mol. Cell Biol. 25, 701\u2013719 (2024).","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"864_CR20","doi-asserted-by":"publisher","first-page":"384","DOI":"10.1038\/s43018-024-00738-9","volume":"5","author":"K Wu","year":"2024","unstructured":"Wu, K., El Zowalaty, A. E., Sayin, V. I. & Papagiannakopoulos, T. The pleiotropic functions of reactive oxygen species in cancer. Nat. Cancer 5, 384\u2013399 (2024).","journal-title":"Nat. Cancer"},{"key":"864_CR21","doi-asserted-by":"publisher","first-page":"1137","DOI":"10.1038\/s41589-019-0408-1","volume":"15","author":"M Conrad","year":"2019","unstructured":"Conrad, M. & Pratt, D. A. The chemical basis of ferroptosis. Nat. Chem. Biol. 15, 1137\u20131147 (2019).","journal-title":"Nat. Chem. Biol."},{"key":"864_CR22","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1038\/s41580-023-00648-1","volume":"25","author":"B Galy","year":"2024","unstructured":"Galy, B., Conrad, M. & Muckenthaler, M. Mechanisms controlling cellular and systemic iron homeostasis. Nat. Rev. Mol. Cell Biol. 25, 133\u2013155 (2024).","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"864_CR23","doi-asserted-by":"publisher","first-page":"173","DOI":"10.1007\/s11684-023-0992-z","volume":"17","author":"X Wang","year":"2023","unstructured":"Wang, X., Zhou, Y., Min, J. & Wang, F. Zooming in and out of ferroptosis in human disease. Front. Med. 17, 173\u2013206 (2023).","journal-title":"Front. Med."},{"key":"864_CR24","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1038\/s41569-022-00735-4","volume":"20","author":"X Fang","year":"2023","unstructured":"Fang, X., Ardehali, H., Min, J. & Wang, F. The molecular and metabolic landscape of iron and ferroptosis in cardiovascular disease. Nat. Rev. Cardiol. 20, 7\u201323 (2023).","journal-title":"Nat. Rev. Cardiol."},{"key":"864_CR25","doi-asserted-by":"publisher","first-page":"271","DOI":"10.1038\/s41392-024-01969-z","volume":"9","author":"Q Ru","year":"2024","unstructured":"Ru, Q. et al. Iron homeostasis and ferroptosis in human diseases: mechanisms and therapeutic prospects. Signal. Transduct. Target. Ther. 9, 271 (2024).","journal-title":"Signal. Transduct. Target. Ther."},{"key":"864_CR26","doi-asserted-by":"publisher","first-page":"424","DOI":"10.1038\/s41580-024-00703-5","volume":"25","author":"SJ Dixon","year":"2024","unstructured":"Dixon, S. J. & Olzmann, J. A. The cell biology of ferroptosis. Nat. Rev. Mol. Cell Biol. 25, 424\u2013442 (2024).","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"864_CR27","doi-asserted-by":"publisher","first-page":"1180","DOI":"10.1038\/ncb3064","volume":"16","author":"JP Friedmann Angeli","year":"2014","unstructured":"Friedmann Angeli, J. P. et al. Inactivation of the ferroptosis regulator Gpx4 triggers acute renal failure in mice. Nat. Cell Biol. 16, 1180\u20131191 (2014).","journal-title":"Nat. Cell Biol."},{"key":"864_CR28","doi-asserted-by":"publisher","first-page":"1060","DOI":"10.1016\/j.cell.2012.03.042","volume":"149","author":"SJ Dixon","year":"2012","unstructured":"Dixon, S. J. et al. Ferroptosis: an iron-dependent form of nonapoptotic cell death. Cell 149, 1060\u20131072 (2012).","journal-title":"Cell"},{"key":"864_CR29","doi-asserted-by":"publisher","first-page":"929","DOI":"10.1038\/s41557-020-0513-5","volume":"12","author":"S M\u00fcller","year":"2020","unstructured":"M\u00fcller, S. et al. CD44 regulates epigenetic plasticity by mediating iron endocytosis. Nat. Chem. 12, 929\u2013938 (2020).","journal-title":"Nat. Chem."},{"key":"864_CR30","doi-asserted-by":"publisher","first-page":"386","DOI":"10.1038\/s41586-023-06017-4","volume":"617","author":"S Solier","year":"2023","unstructured":"Solier, S. et al. A druggable copper-signalling pathway that drives inflammation. Nature 617, 386\u2013394 (2023).","journal-title":"Nature"},{"key":"864_CR31","doi-asserted-by":"publisher","first-page":"492","DOI":"10.1038\/s41586-025-08974-4","volume":"642","author":"T Ca\u00f1eque","year":"2025","unstructured":"Ca\u00f1eque, T. et al. Activation of lysosomal iron triggers ferroptosis in cancer. Nature 642, 492\u2013500 (2025).","journal-title":"Nature"},{"key":"864_CR32","doi-asserted-by":"publisher","DOI":"10.1161\/JAHA.123.031219","volume":"13","author":"K Ishimaru","year":"2024","unstructured":"Ishimaru, K. et al. Deferasirox targeting ferroptosis synergistically ameliorates myocardial ischemia reperfusion injury in conjunction with cyclosporine A. J. Am. Heart Assoc. 13, e031219 (2024).","journal-title":"J. Am. Heart Assoc."},{"key":"864_CR33","doi-asserted-by":"publisher","first-page":"471","DOI":"10.1038\/s43018-022-00355-4","volume":"3","author":"H Alborzinia","year":"2022","unstructured":"Alborzinia, H. et al. MYCN mediates cysteine addiction and sensitizes neuroblastoma to ferroptosis. Nat. Cancer 3, 471\u2013485 (2022).","journal-title":"Nat. Cancer"},{"key":"864_CR34","doi-asserted-by":"publisher","first-page":"113295","DOI":"10.1016\/j.celrep.2023.113295","volume":"42","author":"A-M Zavitsanou","year":"2023","unstructured":"Zavitsanou, A.-M. et al. KEAP1 mutation in lung adenocarcinoma promotes immune evasion and immunotherapy resistance. Cell Rep. 42, 113295 (2023).","journal-title":"Cell Rep."},{"key":"864_CR35","doi-asserted-by":"publisher","first-page":"103211","DOI":"10.1016\/j.redox.2024.103211","volume":"75","author":"C Berndt","year":"2024","unstructured":"Berndt, C. et al. Ferroptosis in health and disease. Redox Biol. 75, 103211 (2024).","journal-title":"Redox Biol."},{"key":"864_CR36","doi-asserted-by":"publisher","first-page":"409","DOI":"10.1016\/j.cell.2017.11.048","volume":"172","author":"I Ingold","year":"2018","unstructured":"Ingold, I. et al. Selenium utilization by GPX4 is required to prevent hydroperoxide-induced ferroptosis. Cell 172, 409\u2013422.e21 (2018).","journal-title":"Cell"},{"key":"864_CR37","doi-asserted-by":"publisher","first-page":"409","DOI":"10.1016\/j.chembiol.2020.03.012","volume":"27","author":"M Conrad","year":"2020","unstructured":"Conrad, M. & Proneth, B. Selenium: tracing another essential element of ferroptotic cell death. Cell Chem. Biol. 27, 409\u2013419 (2020).","journal-title":"Cell Chem. Biol."},{"key":"864_CR38","doi-asserted-by":"publisher","first-page":"1633","DOI":"10.1038\/sj.leu.2402238","volume":"15","author":"PW Gout","year":"2001","unstructured":"Gout, P. W., Buckley, A. R., Simms, C. R. & Bruchovsky, N. Sulfasalazine, a potent suppressor of lymphoma growth by inhibition of the xc\u2013 cystine transporter: a new action for an old drug. Leukemia 15, 1633\u20131640 (2001).","journal-title":"Leukemia"},{"key":"864_CR39","doi-asserted-by":"publisher","first-page":"623","DOI":"10.1016\/j.chembiol.2019.01.008","volume":"26","author":"Y Zhang","year":"2019","unstructured":"Zhang, Y. et al. Imidazole ketone erastin induces ferroptosis and slows tumor growth in a mouse lymphoma model. Cell Chem. Biol. 26, 623\u2013633.e9 (2019).","journal-title":"Cell Chem. Biol."},{"key":"864_CR40","doi-asserted-by":"publisher","first-page":"317","DOI":"10.1016\/j.cell.2013.12.010","volume":"156","author":"WS Yang","year":"2014","unstructured":"Yang, W. S. et al. Regulation of ferroptotic cancer cell death by GPX4. Cell 156, 317\u2013331 (2014).","journal-title":"Cell"},{"key":"864_CR41","doi-asserted-by":"publisher","first-page":"688","DOI":"10.1038\/s41586-019-1705-2","volume":"575","author":"K Bersuker","year":"2019","unstructured":"Bersuker, K. et al. The CoQ oxidoreductase FSP1 acts parallel to GPX4 to inhibit ferroptosis. Nature 575, 688\u2013692 (2019).","journal-title":"Nature"},{"key":"864_CR42","doi-asserted-by":"publisher","first-page":"693","DOI":"10.1038\/s41586-019-1707-0","volume":"575","author":"S Doll","year":"2019","unstructured":"Doll, S. et al. FSP1 is a glutathione-independent ferroptosis suppressor. Nature 575, 693\u2013698 (2019). This study, together with Bersuker et al. (2019), identifies FSP1 as the second mainstay of ferroptosis protection, beyond GPX4.","journal-title":"Nature"},{"key":"864_CR43","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-022-29905-1","volume":"13","author":"P Koppula","year":"2022","unstructured":"Koppula, P. et al. A targetable CoQ\u2013FSP1 axis drives ferroptosis- and radiation-resistance in KEAP1 inactive lung cancers. Nat. Commun. 13, 2206 (2022).","journal-title":"Nat. Commun."},{"key":"864_CR44","doi-asserted-by":"publisher","DOI":"10.1038\/s41419-023-06070-x","volume":"14","author":"JW Kim","year":"2023","unstructured":"Kim, J. W. et al. FSP1 confers ferroptosis resistance in KEAP1 mutant non-small cell lung carcinoma in NRF2-dependent and -independent manner. Cell Death Dis. 14, 567 (2023).","journal-title":"Cell Death Dis."},{"key":"864_CR45","doi-asserted-by":"publisher","first-page":"1090","DOI":"10.1016\/j.chembiol.2023.04.007","volume":"30","author":"JM Hendricks","year":"2023","unstructured":"Hendricks, J. M. et al. Identification of structurally diverse FSP1 inhibitors that sensitize cancer cells to ferroptosis. Cell Chem. Biol. 30, 1090\u20131103.e7 (2023).","journal-title":"Cell Chem. Biol."},{"key":"864_CR46","doi-asserted-by":"publisher","first-page":"371","DOI":"10.1038\/s41586-023-06255-6","volume":"619","author":"T Nakamura","year":"2023","unstructured":"Nakamura, T. et al. Phase separation of FSP1 promotes ferroptosis. Nature 619, 371\u2013377 (2023).","journal-title":"Nature"},{"key":"864_CR47","doi-asserted-by":"publisher","first-page":"1806","DOI":"10.1038\/s41594-023-01136-y","volume":"30","author":"T Nakamura","year":"2023","unstructured":"Nakamura, T. et al. Integrated chemical and genetic screens unveil FSP1 mechanisms of ferroptosis regulation. Nat. Struct. Mol. Biol. 30, 1806\u20131815 (2023).","journal-title":"Nat. Struct. Mol. Biol."},{"key":"864_CR48","doi-asserted-by":"publisher","first-page":"325","DOI":"10.1038\/nrc3038","volume":"11","author":"WH Koppenol","year":"2011","unstructured":"Koppenol, W. H., Bounds, P. L. & Dang, C. V. Otto Warburg\u2019s contributions to current concepts of cancer metabolism. Nat. Rev. Cancer 11, 325\u2013337 (2011).","journal-title":"Nat. Rev. Cancer"},{"key":"864_CR49","doi-asserted-by":"publisher","first-page":"413","DOI":"10.1146\/annurev-cancerbio-030518-055627","volume":"4","author":"WL Wu","year":"2020","unstructured":"Wu, W. L. & Papagiannakopoulos, T. The pleiotropic role of the KEAP1\/NRF2 pathway in cancer. Annu. Rev. Cancer Biol. 4, 413\u2013435 (2020).","journal-title":"Annu. Rev. Cancer Biol."},{"key":"864_CR50","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1016\/j.ccell.2020.06.001","volume":"38","author":"JD Hayes","year":"2020","unstructured":"Hayes, J. D., Dinkova-Kostova, A. T. & Tew, K. D. Oxidative stress in cancer. Cancer Cell 38, 167\u2013197 (2020).","journal-title":"Cancer Cell"},{"key":"864_CR51","doi-asserted-by":"publisher","first-page":"2179","DOI":"10.1101\/gad.225680.113","volume":"27","author":"MC Jaramillo","year":"2013","unstructured":"Jaramillo, M. C. & Zhang, D. D. The emerging role of the Nrf2\u2013Keap1 signaling pathway in cancer. Genes. Dev. 27, 2179\u20132191 (2013).","journal-title":"Genes. Dev."},{"key":"864_CR52","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1016\/j.ccr.2012.05.016","volume":"22","author":"Y Mitsuishi","year":"2012","unstructured":"Mitsuishi, Y. et al. Nrf2 redirects glucose and glutamine into anabolic pathways in metabolic reprogramming. Cancer Cell 22, 66\u201379 (2012).","journal-title":"Cancer Cell"},{"key":"864_CR53","doi-asserted-by":"publisher","first-page":"101107","DOI":"10.1016\/j.redox.2019.101107","volume":"23","author":"M Dodson","year":"2019","unstructured":"Dodson, M., Castro-Portuguez, R. & Zhang, D. D. NRF2 plays a critical role in mitigating lipid peroxidation and ferroptosis. Redox Biol. 23, 101107 (2019).","journal-title":"Redox Biol."},{"key":"864_CR54","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1016\/j.ccell.2018.03.022","volume":"34","author":"M Rojo de la Vega","year":"2018","unstructured":"Rojo de la Vega, M., Chapman, E. & Zhang, D. D. NRF2 and the hallmarks of cancer. Cancer Cell 34, 21\u201343 (2018).","journal-title":"Cancer Cell"},{"key":"864_CR55","doi-asserted-by":"publisher","first-page":"1235","DOI":"10.1093\/carcin\/bgn095","volume":"29","author":"X-J Wang","year":"2008","unstructured":"Wang, X.-J. et al. Nrf2 enhances resistance of cancer cells to chemotherapeutic drugs, the dark side of Nrf2. Carcinogenesis 29, 1235\u20131243 (2008).","journal-title":"Carcinogenesis"},{"key":"864_CR56","doi-asserted-by":"publisher","DOI":"10.1038\/oncsis.2017.65","volume":"6","author":"Z Fan","year":"2017","unstructured":"Fan, Z. et al. Nrf2\u2013Keap1 pathway promotes cell proliferation and diminishes ferroptosis. Oncogenesis 6, e371 (2017).","journal-title":"Oncogenesis"},{"key":"864_CR57","doi-asserted-by":"publisher","first-page":"108444","DOI":"10.1016\/j.celrep.2020.108444","volume":"33","author":"CA Wohlhieter","year":"2020","unstructured":"Wohlhieter, C. A. et al. Concurrent mutations in STK11 and KEAP1 promote ferroptosis protection and SCD1 dependence in lung cancer. Cell Rep. 33, 108444 (2020).","journal-title":"Cell Rep."},{"key":"864_CR58","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1016\/j.ccell.2014.11.019","volume":"27","author":"IS Harris","year":"2015","unstructured":"Harris, I. S. et al. Glutathione and thioredoxin antioxidant pathways synergize to drive cancer initiation and progression. Cancer Cell 27, 211\u2013222 (2015).","journal-title":"Cancer Cell"},{"key":"864_CR59","doi-asserted-by":"publisher","first-page":"9505","DOI":"10.1158\/0008-5472.CAN-10-1509","volume":"70","author":"PK Mandal","year":"2010","unstructured":"Mandal, P. K. et al. Loss of thioredoxin reductase 1 renders tumors highly susceptible to pharmacologic glutathione deprivation. Cancer Res. 70, 9505\u20139514 (2010).","journal-title":"Cancer Res."},{"key":"864_CR60","doi-asserted-by":"publisher","first-page":"2202","DOI":"10.1056\/NEJMra0804577","volume":"362","author":"JM Maris","year":"2010","unstructured":"Maris, J. M. Recent advances in neuroblastoma. N. Engl. J. Med. 362, 2202\u20132211 (2010).","journal-title":"N. Engl. J. Med."},{"key":"864_CR61","doi-asserted-by":"publisher","first-page":"1896","DOI":"10.1158\/0008-5472.CAN-20-1641","volume":"81","author":"KV Floros","year":"2021","unstructured":"Floros, K. V. et al. MYCN-amplified neuroblastoma is addicted to iron and vulnerable to inhibition of the system xc\u2013\/glutathione axis. Cancer Res. 81, 1896\u20131908 (2021).","journal-title":"Cancer Res."},{"key":"864_CR62","doi-asserted-by":"publisher","DOI":"10.1038\/s41419-021-03790-w","volume":"12","author":"Y Lu","year":"2021","unstructured":"Lu, Y. et al. MYCN mediates TFRC-dependent ferroptosis and reveals vulnerabilities in neuroblastoma. Cell Death Dis. 12, 511 (2021).","journal-title":"Cell Death Dis."},{"key":"864_CR63","doi-asserted-by":"publisher","DOI":"10.15252\/emmm.202318014","volume":"15","author":"H Alborzinia","year":"2023","unstructured":"Alborzinia, H. et al. LRP8-mediated selenocysteine uptake is a targetable vulnerability in MYCN-amplified neuroblastoma. EMBO Mol. Med. 15, e18014 (2023).","journal-title":"EMBO Mol. Med."},{"key":"864_CR64","doi-asserted-by":"publisher","first-page":"1398","DOI":"10.1016\/j.bbagen.2019.06.010","volume":"1863","author":"T Nakamura","year":"2019","unstructured":"Nakamura, T., Naguro, I. & Ichijo, H. Iron homeostasis and iron-regulated ROS in cell death, senescence and human diseases. Biochim. Biophys. Acta Gen. Subj. 1863, 1398\u20131409 (2019).","journal-title":"Biochim. Biophys. Acta Gen. Subj."},{"key":"864_CR65","doi-asserted-by":"publisher","first-page":"728","DOI":"10.1016\/j.molcel.2021.12.001","volume":"82","author":"R Rodriguez","year":"2022","unstructured":"Rodriguez, R., Schreiber, S. L. & Conrad, M. Persister cancer cells: iron addiction and vulnerability to ferroptosis. Mol. Cell 82, 728\u2013740 (2022).","journal-title":"Mol. Cell"},{"key":"864_CR66","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1038\/nature13148","volume":"509","author":"JD Mancias","year":"2014","unstructured":"Mancias, J. D., Wang, X., Gygi, S. P., Harper, J. W. & Kimmelman, A. C. Quantitative proteomics identifies NCOA4 as the cargo receptor mediating ferritinophagy. Nature 509, 105\u2013109 (2014).","journal-title":"Nature"},{"key":"864_CR67","doi-asserted-by":"publisher","first-page":"184","DOI":"10.1038\/s41586-024-08285-0","volume":"637","author":"X Zhuang","year":"2025","unstructured":"Zhuang, X. et al. Ageing limits stemness and tumorigenesis by reprogramming iron homeostasis. Nature 637, 184\u2013194 (2025).","journal-title":"Nature"},{"key":"864_CR68","doi-asserted-by":"publisher","first-page":"703","DOI":"10.1016\/j.cell.2008.08.021","volume":"134","author":"PP Hsu","year":"2008","unstructured":"Hsu, P. P. & Sabatini, D. M. Cancer cell metabolism: Warburg and beyond. Cell 134, 703\u2013707 (2008).","journal-title":"Cell"},{"key":"864_CR69","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1007\/978-4-431-55651-0_3","volume-title":"Innovative Medicine","author":"T Berger","year":"2015","unstructured":"Berger, T., Saunders, M. E. & Mak, T. W. in Innovative Medicine 39\u201349 (Springer, 2015)."},{"key":"864_CR70","doi-asserted-by":"publisher","first-page":"732","DOI":"10.1038\/s41580-023-00629-4","volume":"24","author":"PE Czabotar","year":"2023","unstructured":"Czabotar, P. E. & Garcia-Saez, A. J. Mechanisms of BCL-2 family proteins in mitochondrial apoptosis. Nat. Rev. Mol. Cell Biol. 24, 732\u2013748 (2023).","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"864_CR71","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1038\/s41568-021-00407-4","volume":"22","author":"ST Diepstraten","year":"2022","unstructured":"Diepstraten, S. T. et al. The manipulation of apoptosis for cancer therapy using BH3-mimetic drugs. Nat. Rev. Cancer 22, 45\u201364 (2022).","journal-title":"Nat. Rev. Cancer"},{"key":"864_CR72","doi-asserted-by":"publisher","first-page":"202","DOI":"10.1038\/nm.3048","volume":"19","author":"AJ Souers","year":"2013","unstructured":"Souers, A. J. et al. ABT-199, a potent and selective BCL-2 inhibitor, achieves antitumor activity while sparing platelets. Nat. Med. 19, 202\u2013208 (2013).","journal-title":"Nat. Med."},{"key":"864_CR73","doi-asserted-by":"publisher","DOI":"10.1038\/s41580-025-00843-2","author":"E Mishima","year":"2025","unstructured":"Mishima, E. et al. Recommendations for robust and reproducible research on ferroptosis. Nat. Rev. Mol. Cell Biol. https:\/\/doi.org\/10.1038\/s41580-025-00843-2 (2025).","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"864_CR74","doi-asserted-by":"publisher","first-page":"1177","DOI":"10.1016\/j.cell.2024.01.030","volume":"187","author":"B Qiu","year":"2024","unstructured":"Qiu, B. et al. Phospholipids with two polyunsaturated fatty acyl tails promote ferroptosis. Cell 187, 1177\u20131190.e18 (2024).","journal-title":"Cell"},{"key":"864_CR75","doi-asserted-by":"publisher","first-page":"2748","DOI":"10.1016\/j.cell.2023.05.003","volume":"186","author":"D Liang","year":"2023","unstructured":"Liang, D. et al. Ferroptosis surveillance independent of GPX4 and differentially regulated by sex hormones. Cell 186, 2748\u20132764.e22 (2023).","journal-title":"Cell"},{"key":"864_CR76","doi-asserted-by":"publisher","first-page":"124","DOI":"10.1038\/s41556-023-01314-6","volume":"26","author":"W Cui","year":"2024","unstructured":"Cui, W. et al. Gut microbial metabolite facilitates colorectal cancer development via ferroptosis inhibition. Nat. Cell Biol. 26, 124\u2013137 (2024). This study links microbial metabolites to ferroptosis susceptibility, providing an unexpected level of complexity in the regulation of ferroptosis.","journal-title":"Nat. Cell Biol."},{"key":"864_CR77","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1126\/science.aaw9872","volume":"368","author":"MA Badgley","year":"2020","unstructured":"Badgley, M. A. et al. Cysteine depletion induces pancreatic tumor ferroptosis in mice. Science 368, 85\u201389 (2020).","journal-title":"Science"},{"key":"864_CR78","doi-asserted-by":"publisher","first-page":"120","DOI":"10.1038\/nm.4232","volume":"23","author":"SL Cramer","year":"2017","unstructured":"Cramer, S. L. et al. Systemic depletion of l-cyst(e)ine with cyst(e)inase increases reactive oxygen species and suppresses tumor growth. Nat. Med. 23, 120\u2013127 (2017).","journal-title":"Nat. Med."},{"key":"864_CR79","doi-asserted-by":"publisher","first-page":"1181","DOI":"10.1038\/s41556-018-0178-0","volume":"20","author":"Y Zhang","year":"2018","unstructured":"Zhang, Y. et al. BAP1 links metabolic regulation of ferroptosis to tumour suppression. Nat. Cell Biol. 20, 1181\u20131192 (2018).","journal-title":"Nat. Cell Biol."},{"key":"864_CR80","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1038\/nature14344","volume":"520","author":"L Jiang","year":"2015","unstructured":"Jiang, L. et al. Ferroptosis as a p53-mediated activity during tumour suppression. Nature 520, 57\u201362 (2015).","journal-title":"Nature"},{"key":"864_CR81","doi-asserted-by":"publisher","first-page":"8390","DOI":"10.1073\/pnas.1821277116","volume":"116","author":"JI-J Leu","year":"2019","unstructured":"Leu, J. I.-J., Murphy, M. E. & George, D. L. Mechanistic basis for impaired ferroptosis in cells expressing the African-centric S47 variant of p53. Proc. Natl Acad. Sci. USA 116, 8390\u20138396 (2019).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"864_CR82","doi-asserted-by":"publisher","first-page":"118","DOI":"10.1038\/s41586-019-0945-5","volume":"567","author":"J Garcia-Bermudez","year":"2019","unstructured":"Garcia-Bermudez, J. et al. Squalene accumulation in cholesterol auxotrophic lymphomas prevents oxidative cell death. Nature 567, 118\u2013122 (2019).","journal-title":"Nature"},{"key":"864_CR83","doi-asserted-by":"publisher","first-page":"13037","DOI":"10.1021\/ja9029076","volume":"131","author":"L Xu","year":"2009","unstructured":"Xu, L., Davis, T. A. & Porter, N. A. Rate constants for peroxidation of polyunsaturated fatty acids and sterols in solution and in liposomes. J. Am. Chem. Soc. 131, 13037\u201313044 (2009).","journal-title":"J. Am. Chem. Soc."},{"key":"864_CR84","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-024-46386-6","volume":"15","author":"N Yamada","year":"2024","unstructured":"Yamada, N. et al. Inhibition of 7-dehydrocholesterol reductase prevents hepatic ferroptosis under an active state of sterol synthesis. Nat. Commun. 15, 2195 (2024).","journal-title":"Nat. Commun."},{"key":"864_CR85","doi-asserted-by":"publisher","first-page":"401","DOI":"10.1038\/s41586-023-06878-9","volume":"626","author":"FP Freitas","year":"2024","unstructured":"Freitas, F. P. et al. 7-Dehydrocholesterol is an endogenous suppressor of ferroptosis. Nature 626, 401\u2013410 (2024).","journal-title":"Nature"},{"key":"864_CR86","doi-asserted-by":"publisher","first-page":"411","DOI":"10.1038\/s41586-023-06983-9","volume":"626","author":"Y Li","year":"2024","unstructured":"Li, Y. et al. 7-Dehydrocholesterol dictates ferroptosis sensitivity. Nature 626, 411\u2013418 (2024). This study, together with Freitas et al. (2024), demonstrates that 7-DHC represents an endogenous ferroptosis suppressor, providing a compelling mechanism for ferroptosis surveillance beyond GPX4 and FSP1.","journal-title":"Nature"},{"key":"864_CR87","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-022-31963-4","volume":"13","author":"C Bartolacci","year":"2022","unstructured":"Bartolacci, C. et al. Targeting de novo lipogenesis and the lands cycle induces ferroptosis in KRAS-mutant lung cancer. Nat. Commun. 13, 4327 (2022).","journal-title":"Nat. Commun."},{"key":"864_CR88","doi-asserted-by":"publisher","first-page":"1048","DOI":"10.1016\/j.ccell.2023.05.001","volume":"41","author":"JK Minami","year":"2023","unstructured":"Minami, J. K. et al. CDKN2A deletion remodels lipid metabolism to prime glioblastoma for ferroptosis. Cancer Cell 41, 1048\u20131060.e9 (2023).","journal-title":"Cancer Cell"},{"key":"864_CR89","doi-asserted-by":"publisher","first-page":"4492","DOI":"10.1038\/s44318-024-00176-4","volume":"43","author":"MA Banu","year":"2024","unstructured":"Banu, M. A. et al. A cell state-specific metabolic vulnerability to GPX4-dependent ferroptosis in glioblastoma. EMBO J. 43, 4492\u20134521 (2024).","journal-title":"EMBO J."},{"key":"864_CR90","doi-asserted-by":"publisher","first-page":"603","DOI":"10.1038\/s41586-020-2732-8","volume":"585","author":"Y Zou","year":"2020","unstructured":"Zou, Y. et al. Plasticity of ether lipids promotes ferroptosis susceptibility and evasion. Nature 585, 603\u2013608 (2020).","journal-title":"Nature"},{"key":"864_CR91","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-019-09277-9","volume":"10","author":"Y Zou","year":"2019","unstructured":"Zou, Y. et al. A GPX4-dependent cancer cell state underlies the clear-cell morphology and confers sensitivity to ferroptosis. Nat. Commun. 10, 1617 (2019).","journal-title":"Nat. Commun."},{"key":"864_CR92","doi-asserted-by":"publisher","first-page":"5435","DOI":"10.1038\/s41388-018-0315-z","volume":"37","author":"H Miess","year":"2018","unstructured":"Miess, H. et al. The glutathione redox system is essential to prevent ferroptosis caused by impaired lipid metabolism in clear cell renal cell carcinoma. Oncogene 37, 5435\u20135450 (2018).","journal-title":"Oncogene"},{"key":"864_CR93","doi-asserted-by":"publisher","first-page":"112945","DOI":"10.1016\/j.celrep.2023.112945","volume":"42","author":"Z Yang","year":"2023","unstructured":"Yang, Z. et al. HIF-1\u03b1 drives resistance to ferroptosis in solid tumors by promoting lactate production and activating SLC1A1. Cell Rep. 42, 112945 (2023).","journal-title":"Cell Rep."},{"key":"864_CR94","doi-asserted-by":"publisher","first-page":"408","DOI":"10.1161\/CIRCRESAHA.113.279984","volume":"113","author":"M Wortmann","year":"2013","unstructured":"Wortmann, M. et al. Combined deficiency in glutathione peroxidase 4 and vitamin E causes multiorgan thrombus formation and early death in mice. Circ. Res. 113, 408\u2013417 (2013).","journal-title":"Circ. Res."},{"key":"864_CR95","doi-asserted-by":"publisher","first-page":"555","DOI":"10.1084\/jem.20140857","volume":"212","author":"M Matsushita","year":"2015","unstructured":"Matsushita, M. et al. T cell lipid peroxidation induces ferroptosis and prevents immunity to infection. J. Exp. Med. 212, 555\u2013568 (2015).","journal-title":"J. Exp. Med."},{"key":"864_CR96","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1016\/j.redox.2016.05.003","volume":"9","author":"BA Carlson","year":"2016","unstructured":"Carlson, B. A. et al. Glutathione peroxidase 4 and vitamin E cooperatively prevent hepatocellular degeneration. Redox Biol. 9, 22\u201331 (2016).","journal-title":"Redox Biol."},{"key":"864_CR97","doi-asserted-by":"publisher","first-page":"778","DOI":"10.1038\/s41586-022-05022-3","volume":"608","author":"E Mishima","year":"2022","unstructured":"Mishima, E. et al. A non-canonical vitamin K cycle is a potent ferroptosis suppressor. Nature 608, 778\u2013783 (2022).","journal-title":"Nature"},{"key":"864_CR98","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-023-36446-8","volume":"14","author":"D-Y Jin","year":"2023","unstructured":"Jin, D.-Y. et al. A genome-wide CRISPR\u2013Cas9 knockout screen identifies FSP1 as the warfarin-resistant vitamin K reductase. Nat. Commun. 14, 828 (2023).","journal-title":"Nat. Commun."},{"key":"864_CR99","doi-asserted-by":"publisher","first-page":"924","DOI":"10.1038\/s42255-023-00821-y","volume":"5","author":"E Mishima","year":"2023","unstructured":"Mishima, E., Wahida, A., Seibt, T. & Conrad, M. Diverse biological functions of vitamin K: from coagulation to ferroptosis. Nat. Metab. 5, 924\u2013932 (2023).","journal-title":"Nat. Metab."},{"key":"864_CR100","doi-asserted-by":"publisher","first-page":"387","DOI":"10.1007\/s00018-022-04416-w","volume":"79","author":"B Kolbrink","year":"2022","unstructured":"Kolbrink, B. et al. Vitamin K1 inhibits ferroptosis and counteracts a detrimental effect of phenprocoumon in experimental acute kidney injury. Cell. Mol. Life Sci. 79, 387 (2022).","journal-title":"Cell. Mol. Life Sci."},{"key":"864_CR101","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-024-51996-1","volume":"15","author":"J Tschuck","year":"2024","unstructured":"Tschuck, J. et al. Suppression of ferroptosis by vitamin A or radical-trapping antioxidants is essential for neuronal development. Nat. Commun. 15, 7611 (2024).","journal-title":"Nat. Commun."},{"key":"864_CR102","doi-asserted-by":"publisher","first-page":"1474","DOI":"10.1016\/j.cmet.2023.06.014","volume":"35","author":"X Yang","year":"2023","unstructured":"Yang, X. et al. Regulation of VKORC1L1 is critical for p53-mediated tumor suppression through vitamin K metabolism. Cell Metab. 35, 1474\u20131490.e8 (2023).","journal-title":"Cell Metab."},{"key":"864_CR103","doi-asserted-by":"publisher","DOI":"10.1038\/s41419-023-06153-9","volume":"14","author":"L Ferrada","year":"2023","unstructured":"Ferrada, L., Barahona, M. J., Vera, M., Stockwell, B. R. & Nualart, F. Dehydroascorbic acid sensitizes cancer cells to system xc\u2013 inhibition-induced ferroptosis by promoting lipid droplet peroxidation. Cell Death Dis. 14, 637 (2023).","journal-title":"Cell Death Dis."},{"key":"864_CR104","doi-asserted-by":"publisher","first-page":"1317","DOI":"10.1016\/j.ccell.2021.08.006","volume":"39","author":"N Cullin","year":"2021","unstructured":"Cullin, N., Azevedo Antunes, C., Straussman, R., Stein-Thoeringer, C. K. & Elinav, E. Microbiome and cancer. Cancer Cell 39, 1317\u20131341 (2021).","journal-title":"Cancer Cell"},{"key":"864_CR105","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1038\/nature14034","volume":"517","author":"AV Kurtova","year":"2015","unstructured":"Kurtova, A. V. et al. Blocking PGE2-induced tumour repopulation abrogates bladder cancer chemoresistance. Nature 517, 209\u2013213 (2015).","journal-title":"Nature"},{"key":"864_CR106","doi-asserted-by":"publisher","DOI":"10.1136\/jitc-2020-001369","volume":"8","author":"I Efimova","year":"2020","unstructured":"Efimova, I. et al. Vaccination with early ferroptotic cancer cells induces efficient antitumor immunity. J. Immunother. Cancer 8, e001369 (2020).","journal-title":"J. Immunother. Cancer"},{"key":"864_CR107","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-022-31218-2","volume":"13","author":"B Wiernicki","year":"2022","unstructured":"Wiernicki, B. et al. Cancer cells dying from ferroptosis impede dendritic cell-mediated anti-tumor immunity. Nat. Commun. 13, 3676 (2022).","journal-title":"Nat. Commun."},{"key":"864_CR108","doi-asserted-by":"publisher","first-page":"270","DOI":"10.1038\/s41586-019-1170-y","volume":"569","author":"W Wang","year":"2019","unstructured":"Wang, W. et al. CD8+ T cells regulate tumour ferroptosis during cancer immunotherapy. Nature 569, 270\u2013274 (2019).","journal-title":"Nature"},{"key":"864_CR109","doi-asserted-by":"publisher","first-page":"365","DOI":"10.1016\/j.ccell.2022.02.003","volume":"40","author":"P Liao","year":"2022","unstructured":"Liao, P. et al. CD8+ T cells and fatty acids orchestrate tumor ferroptosis and immunity via ACSL4. Cancer Cell 40, 365\u2013378.e6 (2022).","journal-title":"Cancer Cell"},{"key":"864_CR110","doi-asserted-by":"publisher","first-page":"109235","DOI":"10.1016\/j.celrep.2021.109235","volume":"35","author":"C Xu","year":"2021","unstructured":"Xu, C. et al. The glutathione peroxidase Gpx4 prevents lipid peroxidation and ferroptosis to sustain Treg cell activation and suppression of antitumor immunity. Cell Rep. 35, 109235 (2021).","journal-title":"Cell Rep."},{"key":"864_CR111","doi-asserted-by":"publisher","first-page":"1561","DOI":"10.1016\/j.immuni.2021.05.003","volume":"54","author":"S Xu","year":"2021","unstructured":"Xu, S. et al. Uptake of oxidized lipids by the scavenger receptor CD36 promotes lipid peroxidation and dysfunction in CD8+ T cells in tumors. Immunity 54, 1561\u20131577.e7 (2021).","journal-title":"Immunity"},{"key":"864_CR112","doi-asserted-by":"publisher","first-page":"338","DOI":"10.1038\/s41586-022-05443-0","volume":"612","author":"R Kim","year":"2022","unstructured":"Kim, R. et al. Ferroptosis of tumour neutrophils causes immune suppression in cancer. Nature 612, 338\u2013346 (2022).","journal-title":"Nature"},{"key":"864_CR113","doi-asserted-by":"publisher","first-page":"1688","DOI":"10.1016\/j.cmet.2023.09.004","volume":"35","author":"Y Zhao","year":"2023","unstructured":"Zhao, Y. et al. Neutrophils resist ferroptosis and promote breast cancer metastasis through aconitate decarboxylase 1. Cell Metab. 35, 1688\u20131703.e10 (2023).","journal-title":"Cell Metab."},{"key":"864_CR114","doi-asserted-by":"publisher","first-page":"402","DOI":"10.1038\/s41586-019-1426-6","volume":"572","author":"J Wu","year":"2019","unstructured":"Wu, J. et al. Intercellular interaction dictates cancer cell ferroptosis via NF2\u2013YAP signalling. Nature 572, 402\u2013406 (2019).","journal-title":"Nature"},{"key":"864_CR115","doi-asserted-by":"publisher","first-page":"237","DOI":"10.1016\/j.cmet.2008.07.005","volume":"8","author":"A Seiler","year":"2008","unstructured":"Seiler, A. et al. Glutathione peroxidase 4 senses and translates oxidative stress into 12\/15-lipoxygenase dependent- and AIF-mediated cell death. Cell Metab. 8, 237\u2013248 (2008).","journal-title":"Cell Metab."},{"key":"864_CR116","doi-asserted-by":"publisher","first-page":"1042","DOI":"10.1038\/s41556-020-0565-1","volume":"22","author":"M Riegman","year":"2020","unstructured":"Riegman, M. et al. Ferroptosis occurs through an osmotic mechanism and propagates independently of cell rupture. Nat. Cell Biol. 22, 1042\u20131048 (2020).","journal-title":"Nat. Cell Biol."},{"key":"864_CR117","doi-asserted-by":"publisher","first-page":"920","DOI":"10.1016\/j.cmet.2020.10.011","volume":"32","author":"J Zheng","year":"2020","unstructured":"Zheng, J. & Conrad, M. The metabolic underpinnings of ferroptosis. Cell Metab. 32, 920\u2013937 (2020).","journal-title":"Cell Metab."},{"key":"864_CR118","doi-asserted-by":"publisher","first-page":"1470","DOI":"10.1038\/s41556-024-01464-1","volume":"26","author":"A Schwab","year":"2024","unstructured":"Schwab, A. et al. Zeb1 mediates EMT\/plasticity-associated ferroptosis sensitivity in cancer cells by regulating lipogenic enzyme expression and phospholipid composition. Nat. Cell Biol. 26, 1470\u20131481 (2024).","journal-title":"Nat. Cell Biol."},{"key":"864_CR119","doi-asserted-by":"publisher","first-page":"694","DOI":"10.1038\/s41568-024-00737-z","volume":"24","author":"M Russo","year":"2024","unstructured":"Russo, M. et al. Cancer drug-tolerant persister cells: from biological questions to clinical opportunities. Nat. Rev. Cancer 24, 694\u2013717 (2024).","journal-title":"Nat. Rev. Cancer"},{"key":"864_CR120","doi-asserted-by":"publisher","first-page":"247","DOI":"10.1038\/nature24297","volume":"551","author":"MJ Hangauer","year":"2017","unstructured":"Hangauer, M. J. et al. Drug-tolerant persister cancer cells are vulnerable to GPX4 inhibition. Nature 551, 247\u2013250 (2017).","journal-title":"Nature"},{"key":"864_CR121","doi-asserted-by":"publisher","first-page":"453","DOI":"10.1038\/nature23007","volume":"547","author":"VS Viswanathan","year":"2017","unstructured":"Viswanathan, V. S. et al. Dependency of a therapy-resistant state of cancer cells on a lipid peroxidase pathway. Nature 547, 453\u2013457 (2017).","journal-title":"Nature"},{"key":"864_CR122","doi-asserted-by":"publisher","first-page":"890","DOI":"10.1016\/j.ccell.2018.03.017","volume":"33","author":"J Tsoi","year":"2018","unstructured":"Tsoi, J. et al. Multi-stage differentiation defines melanoma subtypes with differential vulnerability to drug-induced iron-dependent oxidative stress. Cancer Cell 33, 890\u2013904.e5 (2018). This study, together with Hangauer et al. (2017) and Viswanathan et al. (2017), represents a seminal study identifying an exquisite sensitivity of drug-tolerant persister cells to ferroptosis.","journal-title":"Cancer Cell"},{"key":"864_CR123","doi-asserted-by":"publisher","first-page":"3356","DOI":"10.1016\/j.cell.2022.07.025","volume":"185","author":"H Kalkavan","year":"2022","unstructured":"Kalkavan, H. et al. Sublethal cytochrome c release generates drug-tolerant persister cells. Cell 185, 3356\u20133374.e22 (2022).","journal-title":"Cell"},{"key":"864_CR124","doi-asserted-by":"publisher","first-page":"795","DOI":"10.1038\/s43018-023-00571-6","volume":"4","author":"H Kalkavan","year":"2023","unstructured":"Kalkavan, H., R\u00fchl, S., Shaw, J. J. P. & Green, D. R. Non-lethal outcomes of engaging regulated cell death pathways in cancer. Nat. Cancer 4, 795\u2013806 (2023).","journal-title":"Nat. Cancer"},{"key":"864_CR125","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1038\/s41586-020-2623-z","volume":"585","author":"JM Ubellacker","year":"2020","unstructured":"Ubellacker, J. M. et al. Lymph protects metastasizing melanoma cells from ferroptosis. Nature 585, 113\u2013118 (2020). This study convincingly shows how metastatic routes may shape the propensity of cancer cells to succumb to ferroptosis depending on the differing microenvironment in lymph or blood.","journal-title":"Nature"},{"key":"864_CR126","doi-asserted-by":"publisher","first-page":"420","DOI":"10.1016\/j.chembiol.2018.11.016","volume":"26","author":"L Magtanong","year":"2019","unstructured":"Magtanong, L. et al. Exogenous monounsaturated fatty acids promote a ferroptosis-resistant cell state. Cell Chem. Biol. 26, 420\u2013432.e9 (2019).","journal-title":"Cell Chem. Biol."},{"key":"864_CR127","doi-asserted-by":"publisher","first-page":"3224","DOI":"10.1002\/ijc.33262","volume":"147","author":"M Sato","year":"2020","unstructured":"Sato, M. et al. Loss of the cystine\/glutamate antiporter in melanoma abrogates tumor metastasis and markedly increases survival rates of mice. Int. J. Cancer 147, 3224\u20133235 (2020).","journal-title":"Int. J. Cancer"},{"key":"864_CR128","doi-asserted-by":"publisher","DOI":"10.1002\/anie.202206277","volume":"61","author":"T Luo","year":"2022","unstructured":"Luo, T. et al. Intracellular delivery of glutathione peroxidase degrader induces ferroptosis in vivo. Angew. Chem. Int. Ed. Engl. 61, e202206277 (2022).","journal-title":"Angew. Chem. Int. Ed. Engl."},{"key":"864_CR129","doi-asserted-by":"publisher","first-page":"E19","DOI":"10.1038\/s41586-023-06270-7","volume":"619","author":"C Mao","year":"2023","unstructured":"Mao, C., Liu, X., Yan, Y., Olszewski, K. & Gan, B. Reply to: DHODH inhibitors sensitize to ferroptosis by FSP1 inhibition. Nature 619, E19\u2013E23 (2023).","journal-title":"Nature"},{"key":"864_CR130","doi-asserted-by":"publisher","first-page":"586","DOI":"10.1038\/s41586-021-03539-7","volume":"593","author":"C Mao","year":"2021","unstructured":"Mao, C. et al. DHODH-mediated ferroptosis defence is a targetable vulnerability in cancer. Nature 593, 586\u2013590 (2021).","journal-title":"Nature"},{"key":"864_CR131","doi-asserted-by":"publisher","first-page":"E9","DOI":"10.1038\/s41586-023-06269-0","volume":"619","author":"E Mishima","year":"2023","unstructured":"Mishima, E. et al. DHODH inhibitors sensitize to ferroptosis by FSP1 inhibition. Nature 619, E9\u2013E18 (2023).","journal-title":"Nature"},{"key":"864_CR132","doi-asserted-by":"publisher","DOI":"10.1038\/s41419-021-03998-w","volume":"12","author":"J Zheng","year":"2021","unstructured":"Zheng, J. et al. Sorafenib fails to trigger ferroptosis across a wide range of cancer cell lines. Cell Death Dis. 12, 698 (2021).","journal-title":"Cell Death Dis."},{"key":"864_CR133","doi-asserted-by":"publisher","first-page":"1732","DOI":"10.1002\/ijc.28159","volume":"133","author":"C Louandre","year":"2013","unstructured":"Louandre, C. et al. Iron-dependent cell death of hepatocellular carcinoma cells exposed to sorafenib: iron-dependent cytotoxicity of sorafenib. Int. J. Cancer 133, 1732\u20131742 (2013).","journal-title":"Int. J. Cancer"},{"key":"864_CR134","doi-asserted-by":"publisher","first-page":"3341","DOI":"10.1172\/JCI99032","volume":"128","author":"B Hassannia","year":"2018","unstructured":"Hassannia, B. et al. Nano-targeted induction of dual ferroptotic mechanisms eradicates high-risk neuroblastoma. J. Clin. Invest. 128, 3341\u20133355 (2018).","journal-title":"J. Clin. Invest."},{"key":"864_CR135","doi-asserted-by":"publisher","first-page":"977","DOI":"10.1038\/nnano.2016.164","volume":"11","author":"SE Kim","year":"2016","unstructured":"Kim, S. E. et al. Ultrasmall nanoparticles induce ferroptosis in nutrient-deprived cancer cells and suppress tumour growth. Nat. Nanotechnol. 11, 977\u2013985 (2016).","journal-title":"Nat. Nanotechnol."},{"key":"864_CR136","doi-asserted-by":"publisher","DOI":"10.1038\/s41419-023-05787-z","volume":"14","author":"TN Xavier da Silva","year":"2023","unstructured":"Xavier da Silva, T. N., Schulte, C., Alves, A. N., Maric, H. M. & Friedmann Angeli, J. P. Molecular characterization of AIFM2\/FSP1 inhibition by iFSP1-like molecules. Cell Death Dis. 14, 281 (2023).","journal-title":"Cell Death Dis."},{"key":"864_CR137","doi-asserted-by":"publisher","first-page":"1673","DOI":"10.1158\/2159-8290.CD-19-0338","volume":"9","author":"X Lang","year":"2019","unstructured":"Lang, X. et al. Radiotherapy and immunotherapy promote tumoral lipid oxidation and ferroptosis via synergistic repression of SLC7A11. Cancer Discov. 9, 1673\u20131685 (2019).","journal-title":"Cancer Discov."},{"key":"864_CR138","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1038\/s41568-022-00529-3","volume":"23","author":"A Wahida","year":"2023","unstructured":"Wahida, A. et al. The coming decade in precision oncology: six riddles. Nat. Rev. Cancer 23, 43\u201354 (2023).","journal-title":"Nat. Rev. Cancer"},{"key":"864_CR139","doi-asserted-by":"publisher","first-page":"442","DOI":"10.1038\/s41418-022-01096-8","volume":"30","author":"F M\u00fcller","year":"2023","unstructured":"M\u00fcller, F. et al. Elevated FSP1 protects KRAS-mutated cells from ferroptosis during tumor initiation. Cell Death Differ. 30, 442\u2013456 (2023).","journal-title":"Cell Death Differ."},{"key":"864_CR140","doi-asserted-by":"publisher","first-page":"470","DOI":"10.1136\/jmedgenet-2013-102218","volume":"51","author":"AC Smith","year":"2014","unstructured":"Smith, A. C. et al. Mutations in the enzyme glutathione peroxidase 4 cause Sedaghatian-type spondylometaphyseal dysplasia. J. Med. Genet. 51, 470\u2013474 (2014).","journal-title":"J. Med. Genet."},{"key":"864_CR141","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1038\/s41589-021-00915-2","volume":"18","author":"H Liu","year":"2022","unstructured":"Liu, H. et al. Characterization of a patient-derived variant of GPX4 for precision therapy. Nat. Chem. Biol. 18, 91\u2013100 (2022).","journal-title":"Nat. Chem. Biol."},{"key":"864_CR142","doi-asserted-by":"publisher","first-page":"145","DOI":"10.15698\/mic2014.05.145","volume":"1","author":"EJ Calabrese","year":"2014","unstructured":"Calabrese, E. J. Hormesis: a fundamental concept in biology. Microb. Cell 1, 145\u2013149 (2014).","journal-title":"Microb. Cell"},{"key":"864_CR143","doi-asserted-by":"publisher","first-page":"719","DOI":"10.1038\/s41589-022-01249-3","volume":"19","author":"AN von Krusenstiern","year":"2023","unstructured":"von Krusenstiern, A. N. et al. Identification of essential sites of lipid peroxidation in ferroptosis. Nat. Chem. Biol. 19, 719\u2013730 (2023).","journal-title":"Nat. Chem. Biol."},{"key":"864_CR144","doi-asserted-by":"publisher","first-page":"286","DOI":"10.1016\/j.cell.2017.03.020","volume":"169","author":"Y-N Gong","year":"2017","unstructured":"Gong, Y.-N. et al. ESCRT-III acts downstream of MLKL to regulate necroptotic cell death and its consequences. Cell 169, 286\u2013300.e16 (2017).","journal-title":"Cell"},{"key":"864_CR145","doi-asserted-by":"publisher","first-page":"1644","DOI":"10.1038\/s41418-020-00691-x","volume":"28","author":"L Pedrera","year":"2021","unstructured":"Pedrera, L. et al. Ferroptotic pores induce Ca2+ fluxes and ESCRT-III activation to modulate cell death kinetics. Cell Death Differ. 28, 1644\u20131657 (2021).","journal-title":"Cell Death Differ."},{"key":"864_CR146","doi-asserted-by":"publisher","first-page":"1164","DOI":"10.1038\/s44318-024-00055-y","volume":"43","author":"S Ramos","year":"2024","unstructured":"Ramos, S., Hartenian, E., Santos, J. C., Walch, P. & Broz, P. NINJ1 induces plasma membrane rupture and release of damage-associated molecular pattern molecules during ferroptosis. EMBO J. 43, 1164\u20131186 (2024).","journal-title":"EMBO J."},{"key":"864_CR147","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1038\/s41586-021-03218-7","volume":"591","author":"N Kayagaki","year":"2021","unstructured":"Kayagaki, N. et al. NINJ1 mediates plasma membrane rupture during lytic cell death. Nature 591, 131\u2013136 (2021).","journal-title":"Nature"},{"key":"864_CR148","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1146\/annurev-pathmechdis-051022-014433","volume":"19","author":"N Kayagaki","year":"2024","unstructured":"Kayagaki, N., Webster, J. D. & Newton, K. Control of cell death in health and disease. Annu. Rev. Pathol. 19, 157\u2013180 (2024).","journal-title":"Annu. Rev. Pathol."},{"key":"864_CR149","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1038\/nrm3737","volume":"15","author":"T Vanden Berghe","year":"2014","unstructured":"Vanden Berghe, T., Linkermann, A., Jouan-Lanhouet, S., Walczak, H. & Vandenabeele, P. Regulated necrosis: the expanding network of non-apoptotic cell death pathways. Nat. Rev. Mol. Cell Biol. 15, 135\u2013147 (2014).","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"864_CR150","doi-asserted-by":"publisher","first-page":"130","DOI":"10.1038\/s41590-017-0013-y","volume":"19","author":"C Holze","year":"2018","unstructured":"Holze, C. et al. Oxeiptosis, a ROS-induced caspase-independent apoptosis-like cell-death pathway. Nat. Immunol. 19, 130\u2013140 (2018).","journal-title":"Nat. Immunol."},{"key":"864_CR151","doi-asserted-by":"crossref","unstructured":"Selye, H. in Psychopathology of Human Adaptation 137\u2013146 (Springer US, 1976).","DOI":"10.1007\/978-1-4684-2238-2_9"},{"key":"864_CR152","doi-asserted-by":"publisher","first-page":"739","DOI":"10.1152\/physrev.00039.2013","volume":"94","author":"VM Labunskyy","year":"2014","unstructured":"Labunskyy, V. M., Hatfield, D. L. & Gladyshev, V. N. Selenoproteins: molecular pathways and physiological roles. Physiol. Rev. 94, 739\u2013777 (2014).","journal-title":"Physiol. Rev."},{"key":"864_CR153","doi-asserted-by":"publisher","first-page":"3289","DOI":"10.1016\/j.bbagen.2012.11.020","volume":"1830","author":"R Brigelius-Floh\u00e9","year":"2013","unstructured":"Brigelius-Floh\u00e9, R. & Maiorino, M. Glutathione peroxidases. Biochim. Biophys. Acta 1830, 3289\u20133303 (2013).","journal-title":"Biochim. Biophys. Acta"},{"key":"864_CR154","doi-asserted-by":"publisher","first-page":"144","DOI":"10.1016\/j.freeradbiomed.2018.09.014","volume":"133","author":"TM Seibt","year":"2019","unstructured":"Seibt, T. M., Proneth, B. & Conrad, M. Role of GPX4 in ferroptosis and its pharmacological implication. Free. Radic. Biol. Med. 133, 144\u2013152 (2019).","journal-title":"Free. Radic. Biol. Med."},{"key":"864_CR155","doi-asserted-by":"publisher","first-page":"4629","DOI":"10.1016\/j.molcel.2024.10.028","volume":"84","author":"J Ito","year":"2024","unstructured":"Ito, J. et al. PRDX6 dictates ferroptosis sensitivity by directing cellular selenium utilization. Mol. Cell 84, 4629\u20134644.e9 (2024).","journal-title":"Mol. Cell"},{"key":"864_CR156","doi-asserted-by":"publisher","first-page":"4645","DOI":"10.1016\/j.molcel.2024.10.027","volume":"84","author":"Z Chen","year":"2024","unstructured":"Chen, Z. et al. PRDX6 contributes to selenocysteine metabolism and ferroptosis resistance. Mol. Cell 84, 4645\u20134659.e9 (2024).","journal-title":"Mol. Cell"},{"key":"864_CR157","doi-asserted-by":"publisher","first-page":"1277","DOI":"10.1038\/s41594-024-01329-z","volume":"31","author":"H Fujita","year":"2024","unstructured":"Fujita, H. et al. PRDX6 augments selenium utilization to limit iron toxicity and ferroptosis. Nat. Struct. Mol. Biol. 31, 1277\u20131285 (2024).","journal-title":"Nat. Struct. Mol. Biol."},{"key":"864_CR158","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1016\/j.abb.2016.12.003","volume":"617","author":"AB Fisher","year":"2017","unstructured":"Fisher, A. B. Peroxiredoxin 6 in the repair of peroxidized cell membranes and cell signaling. Arch. Biochem. Biophys. 617, 68\u201383 (2017).","journal-title":"Arch. Biochem. Biophys."},{"key":"864_CR159","doi-asserted-by":"publisher","first-page":"1062","DOI":"10.1016\/j.tcb.2023.04.005","volume":"33","author":"AF Dos Santos","year":"2023","unstructured":"Dos Santos, A. F., Fazeli, G., Xavier da Silva, T. N. & Friedmann Angeli, J. P. Ferroptosis: mechanisms and implications for cancer development and therapy response. Trends Cell Biol. 33, 1062\u20131076 (2023).","journal-title":"Trends Cell Biol."},{"key":"864_CR160","doi-asserted-by":"publisher","first-page":"1256","DOI":"10.1016\/S0140-6736(11)61452-9","volume":"379","author":"MP Rayman","year":"2012","unstructured":"Rayman, M. P. Selenium and human health. Lancet 379, 1256\u20131268 (2012).","journal-title":"Lancet"},{"key":"864_CR161","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1001\/jama.2008.864","volume":"301","author":"SM Lippman","year":"2009","unstructured":"Lippman, S. M. et al. Effect of selenium and vitamin E on risk of prostate cancer and other cancers: the Selenium and Vitamin E Cancer Prevention Trial (SELECT). JAMA 301, 39\u201351 (2009).","journal-title":"JAMA"},{"key":"864_CR162","doi-asserted-by":"publisher","first-page":"1549","DOI":"10.1001\/jama.2011.1437","volume":"306","author":"EA Klein","year":"2011","unstructured":"Klein, E. A. et al. Vitamin E and the risk of prostate cancer: the Selenium and Vitamin E Cancer Prevention Trial (SELECT). JAMA 306, 1549\u20131556 (2011).","journal-title":"JAMA"},{"key":"864_CR163","doi-asserted-by":"publisher","first-page":"387","DOI":"10.1021\/acscentsci.7b00589","volume":"4","author":"R Shah","year":"2018","unstructured":"Shah, R., Shchepinov, M. S. & Pratt, D. A. Resolving the role of lipoxygenases in the initiation and execution of ferroptosis. ACS Cent. Sci. 4, 387\u2013396 (2018).","journal-title":"ACS Cent. Sci."},{"key":"864_CR164","doi-asserted-by":"publisher","first-page":"15774","DOI":"10.1073\/pnas.1007909107","volume":"107","author":"M Conrad","year":"2010","unstructured":"Conrad, M. et al. 12\/15-Lipoxygenase-derived lipid peroxides control receptor tyrosine kinase signaling through oxidation of protein tyrosine phosphatases. Proc. Natl Acad. Sci. USA 107, 15774\u201315779 (2010).","journal-title":"Proc. Natl Acad. Sci. USA"}],"container-title":["Nature Reviews Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41568-025-00864-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41568-025-00864-1","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41568-025-00864-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,11,24]],"date-time":"2025-11-24T13:02:49Z","timestamp":1763989369000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41568-025-00864-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10,10]]},"references-count":164,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2025,12]]}},"alternative-id":["864"],"URL":"https:\/\/doi.org\/10.1038\/s41568-025-00864-1","relation":{},"ISSN":["1474-175X","1474-1768"],"issn-type":[{"value":"1474-175X","type":"print"},{"value":"1474-1768","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,10,10]]},"assertion":[{"value":"25 July 2025","order":1,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 October 2025","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"M.C. is a co-founder and shareholder of ROSCUE Therapeutics GmbH and holds patents for some of the compounds described herein. A.W. declares no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}